Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
about
HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulationThe Roles of Peroxiredoxin and Thioredoxin in Hydrogen Peroxide Sensing and in Signal TransductionGlutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1)Saitohin, which is nested in the tau locus and confers allele-specific susceptibility to several neurodegenerative diseases, interacts with peroxiredoxin 6Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingOxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death.Phosphorylation and concomitant structural changes in human 2-Cys peroxiredoxin isotype I differentially regulate its peroxidase and molecular chaperone functions.Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.Betanodavirus induces oxidative stress-mediated cell death that prevented by anti-oxidants and zfcatalase in fish cells.Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST.Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors.Analysis of spatial and temporal protein expression in the cerebral cortex after ischemia-reperfusion injuryOn the biomarkers and mechanisms of konzo, a distinct upper motor neuron disease associated with food (cassava) cyanogenic exposure.Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobuleRNA Viruses: ROS-Mediated Cell Death.The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.Redox-regulated chaperones.A novel profluorescent probe for detecting oxidative stress induced by metal and H(2)O(2) in living cells.Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cellsRespiration-dependent H2O2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system.The neuroprotective effect of Klotho is mediated via regulation of members of the redox system.Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.Beta-nodavirus B2 protein induces hydrogen peroxide production, leading to Drp1-recruited mitochondrial fragmentation and cell death via mitochondrial targetingPlacenta proteome analysis from Down syndrome pregnancies for biomarker discovery.Proteomic analysis of novel targets associated with TrkA-mediated tyrosine phosphorylation signaling pathways in SK-N-MC neuroblastoma cells.Expression of a mitochondrial peroxiredoxin prevents programmed cell death in Leishmania donovani.Fuchs endothelial corneal dystrophyPeroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade.Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis.Life-time expression of the proteins peroxiredoxin, beta-synuclein, PARK7/DJ-1, and stathmin in the primary visual and primary somatosensory cortices in rats.Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis.Mitochondrial peroxiredoxin III is a potential target for cancer therapyReduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in miceProtein S-nitrosylation: role for nitric oxide signaling in neuronal death.Peroxiredoxin I regulates the component expression of γ-secretase complex causing the Alzheimer's disease.Differences in the protein expression levels of Trx2 and Prx3 in the hippocampal CA1 region between adult and aged gerbils following transient global cerebral ischemia.Transgenic overexpression of peroxiredoxin-2 attenuates ischemic neuronal injury via suppression of a redox-sensitive pro-death signaling pathwayPeroxiredoxin-2 up-regulation in inflammatory bowel disease: Friend or foe?
P2860
Q24310722-3E634FBE-EECD-4D94-A140-03759586ABE6Q26774284-F197AFE8-5C65-4A0C-A40F-1BDF494C5336Q28085756-0C7D2465-D6C7-4279-A1E1-437044D1475AQ28274071-8B701ADE-F017-4CD8-868C-2F66CB5E59E4Q28389739-10DD5C6A-11D5-4CB7-9ED4-1D8AC1304933Q30350844-7DF0966A-3541-4E62-BB1A-8841C4781FC5Q30352338-14E705AE-45E4-438D-86D4-5EA96FDED201Q30394816-AEE29444-EEDB-41DE-ACC6-65CE2F14ED38Q30542282-31E19717-29B1-4DE4-B755-3ED728DAF18CQ31032741-A3E47833-8362-4628-8C55-C1380311C7FBQ33198937-FDC4FE66-F7D9-446E-B04A-4C7B8F362A8EQ33334024-2943B0BD-2ABA-4957-B8FB-9BA29E61D2D2Q33543964-076359DF-2CFA-4FA2-858D-9B02B4234941Q33594792-F0DC985C-29AD-4A1B-BDF6-28DD72903742Q33600711-5CF51534-3926-44AC-B599-65002DDB77B6Q33643522-81674147-9274-4C31-8B9B-2D78E257272DQ33668416-B59F2C30-1ADC-44B8-BDB3-2B70F8C9D541Q33737263-0302886E-F28C-49B2-9013-12B90B80BC00Q33766707-1FC90701-11CA-4D98-A536-D83BF47307EFQ34008089-247E8130-0B08-4A52-B660-178FCEAF6FF7Q34014666-9BFEAECD-EA65-4A97-8D17-F0BCF22CE6A8Q34107312-ED48F87D-F3D3-4C43-900A-19DF1767F003Q34107408-6ED2922D-6053-4BE2-818D-7253B3375803Q34157658-43C18963-4202-49A7-ABB2-792406111D77Q34202419-F32637F6-6015-4660-BAC5-12038F7541E4Q34331621-DF92EA6B-A44A-459D-A1F7-F8B0FA0F138EQ34547973-AE34417F-526F-40B5-909B-3E1344C35B3AQ34601641-A7FC1AB4-D5B9-42B9-821D-C6C7098E484EQ34624570-63F53464-771E-41AF-8749-087AF4E0975CQ34806527-7EC88771-BE64-4B46-9758-9AE023A8C25BQ35103318-7D433DFA-DEF7-4002-8A0D-BF75A0DFA5B6Q35146028-89280384-4AC1-4536-B649-2858D8CB76ABQ35222138-31291760-8200-4028-A801-EA0BA3984254Q35536098-A955DB5B-79A0-41CC-AC66-46B9D49E5F89Q35606071-A3E3FC06-1CB9-42AB-9259-127C3075F1FCQ35653222-57C822C6-4524-46B5-B652-A33AA1D1E3DFQ35653389-2BEAE79B-557E-40A5-A1AF-4DE9CD7FD80EQ35728833-E8C07902-064F-4C4A-9438-CAE3B20D17A8Q36070865-B52513AC-2597-4CE5-8C72-37D8787195E4Q36199233-60AF22B3-B44E-4296-BA31-DC3B09581C08
P2860
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@ast
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@en
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@nl
type
label
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@ast
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@en
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@nl
prefLabel
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@ast
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@en
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@nl
P2093
P1433
P1476
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
@en
P2093
Ephrem Engidawork
Gert Lubec
Kurt Krapfenbauer
Michael Fountoulakis
Nigel Cairns
P304
P356
10.1016/S0006-8993(02)04243-9
P407
P577
2003-03-28T00:00:00Z